Medical Device Recalls by USFDA: an Evaluation of Regulatory Framework and Industry Practices

Abstract

Medical device recalls pose significant risks to patient safety and public health, underscoring the critical role of regulatory frameworks and industry practices in mitigating these risks. This review evaluates the United States Food and Drug Administration’s (USFDA) regulatory framework for medical device recalls and examines industry practices to identify strengths, gaps, and opportunities for improvement. A mixed-methods approach was employed, combining qualitative analysis of USFDA policies, case studies of high-profile recalls, and quantitative assessment of recall trends from 2010 to 2020. Key findings reveal that recall effectiveness is influenced by factors such as device classification, manufacturer compliance, and post-market surveillance. Design flaws and manufacturing defects were the leading causes of recalls, with implantable devices (e.g., pacemakers, hip replacements) being the most frequently affected. The study highlights regulatory challenges, including inadequate pre-market testing and inconsistent post-market monitoring, while emphasizing the importance of communication and collaboration between regulators, manufacturers, and healthcare providers. Recommendations include streamlining recall processes, enhancing transparency, and adopting advanced surveillance technologies. The review concludes that a patient-centered approach, supported by robust regulatory oversight and industry accountability, is essential for improving recall management and ensuring long-term device safety.